Abstract
It is generally assumed that ethanol exerts its effects in the central nervous system (CNS) by perturbing the normal processes of information conduction and transmission. Using electrophysiologic techniques, one can directly assess the effects of ethanol on neuronal activity, and such studies have been performed (e.g., see reference 1). However, insights into the molecular mechanisms by which ethanol affects neuronal activity have, at present, been derived primarily from neurochemical assessments of ethanol’s actions. In the CNS, as in the peripheral nervous system, rates of neurotransmitter metabolism usually reflect the level of neuronal activity,2,3 and one can assess responses to ethanol by determining ethanol’s effect on neurotransmitter synthesis, release, and metabolism and/or by measuring the interactions of neurotransmitters with specific receptors in the presence of ethanol. The results of such studies provide the basis for this review.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kalant H, Woo N: Electrophysiological effects of ethanol on the nervous system. Pharmacol Ther 14: 431–457, 1981
Aghajanian GK, Bunney BS, Kuhar Mk Use of single unit recording in correlating transmitter turnover with impulse flow in monoamine neurons, in Mandel Ai (ed): New Concepts in Neurotransmitter Regulation. New York, Plenum Press, 1973, p 115
Herr BE, Gallagher DW, Roth RH: Tryptophan hydroxylase: Activation in vivo following stimulation of central serotonergic neurons. Biochem Pharmacol 24: 2019–2023, 1975
Karper C: Neuropathology of brain damage caused by alcohol. Med J Aust 2: 277–282, 1982
Riley JN, Walker DW: Morphological alterations in hippocampus after long-term alcohol consumption in mice. Science 201: 646–648, 1978
Golden CJ, Graber B, Blose, 1, et al: Difference in brain densities between chronic alcoholic and normal control patients. Science 211: 508–510, 1981
Tabakoff B, Melchior CL, Hoffman PL: Commentary on ethanol tolerance. Alcoholism: Clin Exp Res 6: 252–259, 1982
Jaffe JH: Drug addiction and drug abuse, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, ed 5. New York, Macmillan Co, 1970, p 284
Tabakoff B, Ritzmann RF: The effects of 6-hydroxydopamine on tolerance to and dependence on ethanol. J Pharmacol Exp Ther 203: 319–331, 1977
Tabakoff B, Rothstein JD: The biology of tolerance and dependence, in Tabakoff B, Sutker PB, Randall CL (eds): Medical and Social Aspects of Alcohol Abuse. New York, Plenum Press, 1983, p 187
Israel Y, Kalant H, LeBlanc AE: Effect of lower alcohols on potassium transport and microsomal adenosine triphosphatase activity of rat cerebral cortex. Biochem J 100: 27–33, 1966
Sun AY, Samorajski T: Effects of ethanol on the activity of adenosine triphosphatase and acetylcholinesterase in synaptosomes isolated from guinea pig brain. J Neurochem 17: 1365–1372, 1970
Tabakoff B: Inhibition of sodium, potassium and magnesium-activated ATP ases by acetaldehyde and biogenic aldehydes. Res Commun Chem Pathol Pharmacol 7: 621–624, 1974
Westcott JY, Weiner H: Effect of ethanol on synaptosomal (Na+-K+)ATPase in control and ethanol-dependent rats. Arch Biochem Biophys 223: 51–57, 1983
Rangaraj N, Kalant H: Interaction of ethanol and catecholamines on rat brain (Na +-K+)ATPase. Can J Physiol Pharmacol 57: 1098–1106, 1979
Israel Y, Kalant H, LeBlanc AE, et al: Changes in cation transport and (Na+-K+)-activated adenosine triphosphatase produced by chronic administration of ethanol. J Pharmacol Exp Ther 174: 330–336, 1970
Knox WH, Perrin GR, Sen AK: Effect of chronic administration of ethanol on (Na +-K+)-activated ATPase activity in six areas of the cat brain. J Neurochem 19: 2881–2884, 1972
Guerri C, Grisolia S: Effects of prenatal and postnatal exposure of rats to alcohol: Changes in (Na+-K+)ATPase. Pharmacol Biochem Behav 17: 927–932, 1982
Goldstein DB, Israel Y: Effects of ethanol on mouse brain (Na+-K+)-activated adenosine triphosphatase. Life Sci (Part II ) 2: 957–963, 1972
Akera T, Rech RH, Marquis TT, et al: Lack of relationship between brain (Na + + K+)-activated adenosine triphosphatase and the development of tolerance to ethanol in rats. J Pharmacol Exp Ther 185: 594–601, 1973
Rangaraj N, Kalant H: Effects of ethanol withdrawal, stress and amphetamine on rat brain (Na +-K+)ATPase. Biochem Pharmacol 27: 1139–1144, 1978
Desaiah D, Ho IK: Kinetics of catecholamine-sensitive (Nat -K+)ATPase activity in mouse brain synaptosomes. Biochem Pharmacol 26: 2029–2035, 1977
Levental M, Tabakoff, B: Sodium-potassium-activated adenosine triphosphatase activity as a measure of neuronal membrane characteristics in ethanol-tolerant mice. J Pharmacol Exp Ther 212: 315–319, 1980
Rangaraj N, Kalant H: Effect of chronic ethanol treatment on temperature dependence and on norepinephrine sensitization of rat brain (Nat -K+) adenosine triphosphatase. J Pharmacol Exp Ther 223: 536–539, 1982
Rangaraj N, Kalant H: Effect of chronic ethanol treatment on temperature dependence and on norepinephrine sensitization of rat brain (Nat + K+) adenosine triphosphatase. J Pharmacol Exp Ther 223: 536–539, 1982
Ross DH, Medina MA, Cardenas HL: Morphine and ethanol: Selective depletion of regional brain calcium. Science 186: 63–65, 1974
Ross DH: Adaptive changes in Ca“-membrane interactions following chronic ethanol exposure. Adv Exp Med Biol 85A: 459–471, 1977
Ross DH, Kibler BC, Cardenas HL: Modification of glycoprotein residues as Ca++ receptor sites after chronic ethanol exposure. Drug Alcohol Depend 2: 305–315, 1977
Michaelis EK, Myers SL: Calcium binding to brain synaptosomes. Biochem Pharmacol 28: 2081–2087, 1979
Harris RA, Hood WF: Inhibition of synaptosomal calcium uptake by ethanol. J Pharmacol Exp Ther 213: 562–568, 1980
Stokes JA, Harris RA: Alcohols and synaptosomal calcium transport. Mol Pharmacol 22: 99–104, 1982
Friedman MB, Erickson CD, Leslie SW: Effects of acute and chronic ethanol administration on whole mouse brain synaptosomal calcium influx. Biochem Pharmacol 29: 1903–1908, 1980
Nachsen DA, Blaustein MP: Some properties of potassium-stimulated calcium influx in pre-synaptic nerve endings. J Gen Physiol 76: 709–729, 1980
Michaelis ML, Michaelis EK: Alcohol and local anesthetic effects on Na +-dependent Ca ++ fluxes in brain synaptic membrane vesicles. Biochem Pharmacol 32: 963–969, 1983
Michaelis ML, Michaelis EK, Tehan T: Alcohol effects on synaptic membrane calcium ion fluxes. Pharmacol Biochem Behav 18 (Suppl 1): 19–23, 1983
Carlen PL, Gurevich N, Durand D: Ethanol in low doses augments calcium-mediated mechanisms measured intracellularly in hippocampal neurons. Science 215: 306–309, 1982
Yamamoto HA, Harris RA: Calcium-dependent 86Rb efflux and ethanol intoxication: Studies of human red blood cells and rodent brain synaptosomes. Eur J Pharmacol 88: 357–363, 1983
Harris RA: Ethanol and pentobarbital inhibition of intrasynaptosomal sequestration of calcium. Biochem Pharmacol 30: 3209–3215, 1981
Erickson CK, Tyler TD: Ethanol: Modification of acute intoxication by divalent cations. Science 199: 1219–1221, 1978
Harris RA: Alteration of alcohol effects by calcium and other inorganic cations. Pharmacol Biochem Behav 10: 527–534, 1979
Tabakoff B, Hoffman PL: Neurochemical aspects of tolerance to and physical dependence on alcohol, in Kissin B, Begleiter H (eds): The Biology of Alcoholism, vol 7. New York, Plenum Press, 1983, p 199
Pohorecky LA: Biphasic action of ethanol. Biobehav Rev 1: 231–240, 1977.
Towle AC, Sze PY: Chronic ethanol reduces brain calmodulin levels. Trans Am Soc Neurochem 12: 88, 1981
Luthin GR, Tabakoff B: Effects of ethanol on calmodulin levels in mouse striatum and cerebral cortex. Alcoholism: Clin Exp Res 8: 68–72, 1984
Tabakoff B, Hoffman PL: Alcohol and neurotransmitters, in Rigter H, Crabbe JC Jr (eds): Alcohol Tolerance and Dependence. Amsterdam, ElsevierfNorth-Holland Biomedical Press, 1980, p 201
Bacopoulos NG, Bhatanger RK, van Orden LS III: The effects of subhypnotic doses of ethanol on regional catecholamine turnover. J Pharmacol Exp Ther 204: 1–10, 1978
Hunt WA, Majchrowicz E: Alterations in the turnover of brain norepinephrine and dopamine in the alcohol-dependent rat. J Neurochem 23: 549–552, 1974
Aston-Jones G, Foote SL, Bloom FE: Low doses of ethanol disrupt sensory responses of brain noradrenergic neurons. Nature (London) 296: 857–860, 1982
Pohorecky LA, Brick J: Activity of neurons in the locus coeruleus of the rat: Inhibition by ethanol. Brain Res 131: 174–179, 1977
Strahlendorf JC, Strahlendorf HK: Response of locus coeruleus neurons to direct application of ethanol. Neurosci Abstr 7: 312, 1982
Shefner SA, Tabakoff B: Basal firing rate of rat locus coerulus neurons affects sensitivity to ethanol. Alcohol,in press
DeTurck KH, Vogel WH: Effects of acute ethanol on plasma and brain catecholamine levels in stressed and unstressed rats: Evidence for an ethanol-stress interaction. J Pharmacol Exp Ther 223: 348–354, 1982
Pohorecky LA: Effects of ethanol on central and peripheral noradrenergic neurons. J Pharmacol Exp Ther 189: 380–391, 1974
Borg S, Kvande H, Mossberg D, et al: Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacol Biochem Behav 18 (Suppl 1): 375–378, 1983
Borg S, Kvande H, Sedvall G: Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 213: 1135–1137, 1983
Borg S, Czarnecka A, Kvande H, et al: Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine in male alcoholic patients during withdrawal. Alcoholism: Clin Exp Res 7: 411–415, 1983
Davis VE, Brown H, Hoff JA, et al: Ethanol-induced alterations of norepinephrine metabolism in man. J Lab Clin Med 69: 787–799, 1967
Wolfe BB, Harden TK, Molinoff PB: In vitro study of beta-adrenergic receptors. Annu Rev Pharmacol Toxicol 17: 575–604, 1977
Sporn JR Harden RK, Wolfe BB, et al.: Beta-adrenergic receptor involvement in 6-hydroxydopamine-induced supersensitivity in rat cerebral cortex. Science 194:624–625, 1976
Minneman KP, Dibner MD, Wolfe BB, et al: 131 and ß2-adrenergic receptors in rat cerebral cortex are independently regulated. Science 204: 866–868, 1979
Chin JH, Goldstein DB: Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes. Mol Pharmacol 13: 435–441, 1977
Rodbell M: The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284: 17–22, 1980
French SW, Palmer DS, Narod NE, et al: Noradrenergic sensitivity of the cerebral cortex after chronic ethanol ingestion and withdrawal. J Pharmacol Exp Ther 194: 319–326, 1975
Banerjee SV, Sharma VK, Khanna JM: Alterations in beta-adrenergic receptor binding during ethanol withdrawal. Nature 276: 407–409, 1978
Rabin RA, Wolfe BB, Dibner, et al: Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther 213: 491–496, 1980
Tabakoff B, Luthin GR, Saito T, et al: Effects of ethanol on receptor-adenylate cyclase coupling. Fed Proc 42: 902, 1983
Bustos G, Liberona JL, Gysling K: Regulation of transmitter synthesis and release in mesolimbic dopaminergic nerve terminals. Effect of ethanol. Biochem Pharmacol 30: 2157–2164, 1981
Morgenroth VH, Walters JR, Roth RH: Dopaminergic neurons—Alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem Pharmacol 25: 655–661, 1976
Bustos G, Roth RH: Effect of acute ethanol treatment on transmitter synthesis and metabolism in central dopaminergic neurons. J Pharm Pharmacol 28: 580–582, 1976
Urwyler S, Tabakoff B: Stimulation of dopamine synthesis and release by morphine and [2D-Ala, 5-D-Leu]enkephalin in the mouse striatum in vivo. Life Sci 28: 2277–2286, 1981
Kehr W, Carlsson A, Lindqvist M: A method for determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. N-S Arch Pharmacol 274: 273–280, 1972
Kiianmaa K, Tabakoff B: Neurochemical correlates of tolerance and strain differences in the neurochemical effects of ethanol. Pharmacol Biochem Behav 18 (Suppl 1): 383–388, 1983
Carlsson A, Magnusson J, Svensson TH, et al: Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia 30: 27–36, 1973
Carlsson A, Engel J, Strombom U, et al: Suppression by dopamine agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. N-S Arch Pharmacol 283: 117–128, 1974
Corrodi H, Fuxe K, Hokfelt T: The effect of ethanol on the activity of central catecholamine neurones in rat brain. J Pharm Pharmacol 18: 821–823, 1966
Carlsson A, Lindqvist M: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J Pharm Pharmacol 25: 437 440, 1973
Hunt WA, Majchrowicz E: Studies of neurotransmitter interactions after acute and chronic ethanol administration. Pharmacol Biochem Behav 18 (Suppl 1): 371–374, 1983
Karoum F, Wyatt RJ, Majchrowicz E: Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats. Br J Pharmacol 56: 403–411, 1976
Lai H, Makous WL, Horita A, et al: Effects of ethanol on turnover and function of striatal dopamine. Psychopharmacology 61: 1–9, 1979
Barbaccia ML, Bosio A, Spano PF, et al: Ethanol metabolism and striatal dopamine turnover. J Neural Transm 53: 169–177, 1982
Fadda F, Argiolas A, Melis MR, et al: Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra. Life Sci 27: 979–986, 1980
Baizer L, Masserano 1M, Weiner N: Ethanol-induced changes in tyrosine hydroxylase activity in brains of mice selectively bred for differences in sensitivity to ethanol. Pharmacol Biochem Behav 15: 945–949, 1981
Alkana RL, Parker ES, Malcolm RD, et al: Interaction of apomorphine and amantadine with ethanol in men. Alcoholism: Clin Exp Res 6: 403–411, 1982
Major LF, Ballenger JC, Goodwin FK, et al: Cerebrospinal fluid homovanillic acid in male alcoholics: Effects of disulfiram. Biol Psychiatry 12: 635–642, 1977
Orenberg EK, Zarcone VP, Renson JF, et al: The effects of ethanol ingestion on cyclic AMP, homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Life Sci 19: 1669–1672, 1976
Ritzmann, RF, Tabakoff B: Body temperature in mice: A quantitative measure of alcohol tolerance and physical dependence. J Pharmacol Exp Ther 199: 158–170, 1976
Lucchi L, Lupini M, Govoni S, et al: Ethanol and dopaminergic systems. Pharmacol Biochem Behav 18 (Suppl 1): 379–382, 1983
Tabakoff B, Hoffman PL: Alterations in receptors controlling dopamine synthesis after chronic ethanol ingestion. J Neurochem 31: 1223–1229, 1978
Ahtee L, Svarstrom-Fraser M: Effect of ethanol dependence and withdrawal on the catecholamines in rat brain and heart. Acta Pharmacol Toxicol 36: 289–298, 1975
Darden JH, Hunt WA: Reduction of striatal dopamine release during an ethanol withdrawal syndrome. J Neurochem 29: 1143–1145, 1977
Mullin Mi, Ferko, AP: Alterations in dopaminergic function after subacute ethanol administration. J Pharmacol Exp Ther 225: 694–698, 1983
Liljequist S, Engel J: The effect of chronic ethanol administration on central neurotransmitter mechanisms. Med Biol 57: 199–210, 1979
Borg V, Weinholdt T: Bromocriptine in the treatment of the alcohol withdrawal syndrome. Acta Psychiatr Scand 65: 101–111, 1982
Seeman P: Brain dopamine receptors. Pharmacol Rev 32: 229–313, 1980
Hruska RE, Silbergeld EK: Inhibition of 3H-spiroperidol binding by in vitro addition of ethanol. J Neurochem 35: 750–752, 1980
Rabin RA, Molinoff PB: Activation of adenylate cyclase by ethanol in mouse striatal tissue. J Pharmacol Exp Ther 216: 129–134, 1981
Tabakoff B, Hoffman PL: Development of functional dependence on ethanol in dopaminergic systems. J Pharmacol Exp Ther 208: 216–222, 1979
Barbaccia ML, Bosio A, Lucchi L, et al: Neuronal mechanisms regulating ethanol effects on the dopaminergic system. Life Sci 30: 2163–2170, 1982
Engel J, Liljequist S: The effect of long-term ethanol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens. Psychopharmacology 49: 253–257, 1976
Liljequist S: Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration. Acta Pharmacol 43: 19–28, 1978
Tabakoff B, Hoffman PL, Ritzmann RF: Dopamine receptor function after chronic ingestion of ethanol. Life Sci 23: 643–648, 1978
Black RF, Hoffman PL, Tabakoff B: Receptor-mediated dopaminergic function after ethanol withdrawal. Alcoholism: Clin Exp Res 4: 294–297, 1980
Van Thiel DH, Gavaler JS, Lester R, et al: Plasma estrone, prolactin, neurophysin and sex steroid-binding globulin in chronic alcoholic men. Metabolism 24: 1015–1019, 1975
Majumdar SK: Serum prolactin levels during the hangover phase of the ethanol withdrawal syndrome. Neuroendocrinol Lett 4: 253–259, 1982
Neill JD, Frawley LS, Plostky PM, et al: Dopamine in hypophyseal stalk blood of the Rhesus monkey and its role in regulating prolactin secretion. Endocrinology 108: 489–494, 1981
Seilicovich A, Rettori V, Koch OR, et al: The effect of acute and chronic ethanol administration on prolactin secretion in male rats. J Androl 3: 344–348, 1982
Pokras R, Tabakoff B: Ethanol alters the sensitivity of the dopamine receptor mediating the inhibition of prolactin release. Alcoholism: Clin Exp Res 6: 151, 1982
Pokras R, Tabakoff B: On the mechanism by which dopamine inhibits prolactin release in the anterior pituitary. Life Sci 31: 2587–2593, 1982
Tabakoff B, Ritzmann RF, Boggan WO: Inhibition of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem 24: 1043–1051, 1975
Weingartner H, Rudorfer MV, Buchsbaum MS, et al: Effect of serotonin on memory impairments produced by ethanol. Science 221: 472–474, 1983
ll. Branchey L, Shaw S, Lieber CS: Ethanol impairs tryptophan transport into the brain and depresses serotonin. Life Sci 29: 2751–2755, 1981
Tabakoff B, Hoffman PL, Moses F: Neurochemical correlates of ethanol withdrawal: Alterations in serotonergic function. J Pharm Pharmacol 29: 471–476, 1977
Collier HOJ, Hammond MD, Schneider C: Effects of drugs affecting endogenous amines or cyclic nucleotides on ethanol withdrawal head twitches in mice. Br J Pharmacol 58: 9–16, 1976
Carmichael FJ, Israel Y: Effects of ethanol on neurotransmitter release by rat brain cortical slices. J Pharmacol Exp Ther 193: 824–834, 1975
Kalant H, Israel Y, Mahon MA: The effect of ethanol on acetylcholine synthesis, release and degradation in brain. Can J Physiol Pharmacol 45: 172–176, 1967
Erickson CK, Graham DT: Alteration of cortical and reticular acetylcholine release by ethanol in vivo. J Pharmacol Exp Ther 185: 583–593, 1973
Sinclair JG, Lo GF: Acute tolerance to ethanol on the release of acetylcholine from the cat cerebral cortex. Can J Physiol Pharmacol 56: 668–670, 1978
Hunt WA, Dalton TK: Regional brain acetylcholine levels in rats acutely treated with ethanol or rendered ethanol dependent. Brain Res 109: 628–631, 1976
Cohen EL, Wurtman RJ: Brain acetylcholine: Increase after systemic choline administration. Life Sci 16: 1095–1102, 1975
Kuhar MJ, Murrin LC: Sodium-dependent high affinity choline uptake. J Neurochem 30: 15–21, 1978
Murrin LC, de Haven RN, Kuhar MJ: On the relationship between 3H-choline uptake activation and 3H-acetylcholine release. J Neurochem 29: 681–687, 1977
Durkin TP, Hashem-Zadeh H, Mandel P, et al: A comparative study of the acute effects of ethanol on the cholinergic system in hippocampus and striatum of inbred mouse strains. J Pharmacol Exp Ther 220: 203–208, 1982
Howerton TC, Marks MJ, Collins AC: Norepinephrine, gamma-aminobutyric acid and choline reuptake kinetics and the effects of ethanol in long-sleep and short-sleep mice. Subst Alcohol Actions Misuse 3: 89–99, 1982
Hunt WA, Majchrowicz E, Dalton T: Alterations in high-affinity choline uptake in brain after acute and chronic ethanol treatment. J Pharmacol Exp Ther 210: 259–263, 1979
Clark JW, Kalant H, Carmichael FJ: Effect of ethanol tolerance on release of acetylcholine and norepinephrine by rat cerebral cortex slices. Can J Physiol Pharmacol 55: 758–768, 1977
Rawat AK: Brain levels and turnover rates of presumptive neurotransmitters as influenced by administration and withdrawal of ethanol in mice. J Neurochem 22: 915–922, 1974
Ebel A, Vigran R, Mack G, et al: Cholinergic involvement in ethanol intoxication and withdrawal-induced seizure susceptibility. Psychopharmacology 61: 251–254, 1979
Nordberg A, Larsson C, Perdahl E, et al: Changes in cholinergic activity in human hippocampus following chronic alcohol abuse. Pharmacol Biochem Behav 18 (Suppl 1): 397–400, 1983
Tabakoff B, Munoz-Marcus M, Fields JZ: Chronic ethanol feeding produces an increase in msucarinic cholinergic receptors in mouse brain. Life Sci 25: 2173–2180, 1979
Nordberg A, Wahlstrom G: Tolerance, physical dependence and changes in msucarinic receptor binding sites after chronic ethanol treatment in the rat. Life Sci 31: 277–287, 1982
Yoshida K, Engel J, Liljequist S: The effect of chronic ethanol administration on high affinity 3H-nicotinic binding in rat brain. N-S Arch Pharmacol 321: 74–76, 1982
Smith CM: The pharmacology of sedative/hypnotics, alcohol and anesthetics: Sites and mechanisms of action, in Martin W (ed): Handbook of Experimental Pharmacology, Vol 45(1). Berlin, Springer-Verlag, 1977, p 413
Liljequist S, Engel J: Effects of GABA ergic agonists and antagonists on various ethanol-induced behavioral changes. Psychopharmacology 78: 71–75, 1982
Frye GD, Breese, GR: GABA ergic modulation of ethanol-induced motor impairment. J Pharmacol Exp Ther 223: 750–756, 1982
Martz A, Deitrich RA, Harris RA: Behavioral evidence for the involvement of gammaaminobutyric acid in the actions of ethanol. Eur J Pharmacol 89: 53–62, 1983
Sutton I, Simmonds MA: Effects of acute and chronic ethanol on the gamma-aminobutyric acid system in rat brain. Biochem Pharmacol 22: 1685–1692, 1973
Hakkinen HM, Kulonen E: Ethanol intoxication and the activities of glutamate decarboxylase and gamma-aminobutyric aminotransferase in rat brain. J Neurochem 33: 943–946, 1979
Wixon HN, Hunt WA: Effect of acute and chronic ethanol treatment on gamma-aminobutyric acid levels and on aminooxyacetic acid-induced GABA accumulation. Subst Alcohol Actions Misuse 1:481–491, 1980
Volicer L, Klosowicz BA: Effect of ethanol and stress on gamma-aminobutyric acid and guanosine 3’,5’-monophosphate levels in the rat brain. Biochem Pharmacol 28: 2677–2679, 1979
Sytinsky IA, Guzikov BM, Gomanko MV, et al: The gamma-aminobutyric acid (GABA) system in brain during acute and chronic ethanol intoxication. J Neurochem 25: 43–48, 1975
Leitch GL, Backes DJ, Siegman FS, et al: Possible role of GABA in the development of tolerance to alcohol. Experientia 33: 496–497, 1977
Claus D, Kim JS, Kornhuber ME, et al: Einfluss von aethanol auf die neurotransmitter glutamat and GABA. Arch Psychiatr Nervenkr 232: 183–189, 1982
Volicer L: GABA levels and receptor binding after acute and chronic ethanol administration. Brain Res Bull 5: 809–813, 1980
Cooper BR, Viik K, Ferris RM, et al: Antagonism of the enhanced susceptibility to audiogenic seizures during alcohol withdrawal in the rat by gamma-aminobutyric acid (GABA) and GABAmimetic agents. J Pharmacol Exp Ther 209: 396–403, 1979
Ticku MK, Burch T: Alterations in gamma-aminobutyric acid receptor sensitivity following acute and chronic ethanol treatment. J Neurochem 34: 417–423, 1980
Ticku MK: The effects of acute and chronic ethanol administration and its withdrawal on gamma-aminobutyric acid receptor binding in rat brain. Br J Pharmacol 70: 403–410, 1980
Linnoila M, Stowell L, Marangos PJ, et al: Effect of ethanol and ethanol withdrawal on 3Hmuscimol binding and behavior in the rat: A pilot study. Acta Pharmacol Toxicol 49: 407–411, 1981
Rohde BH, Harris RA: GABA and flunitrazepam binding to neuroblastoma cell membranes—Effects of growth conditions, ethanol and pentobarbital. Brain Res 253: 133–141, 1982
Unwin JW, Taberner PV: Sex and strain differences in GABA receptor binding after chronic ethanol drinking in mice. Neuropharmacology 19: 1257–1259, 1980
Volicer L, Biagoni TM: Effect of ethanol administration and withdrawal on GABA receptor binding in rat cerebral cortex. Subst Alcohol Actions Misuse 3: 31–39, 1982
Liljequist S, Engel J: Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration. J Neural Transm 46: 195–204, 1979
Bosio A, Lucchi L, Spano PF, et al: Central toxic effects of chronic ethanol treatment: Actions on GABA and benzodiazepine recognition sites. Toxicol Lett 13: 99–104, 1982
Sellers EM, Busto U: Benzodiazepines and ethanol: Assessment of the effects and consequences of psychotropic drug interactions. J Clin Psychopharmacol 2: 249–262, 1982
Mattila MJ, Aranko K, Seppala T: Acute effects of buspirone and alcohol on psychomotor skills. J Clin Psychiatry 43: 56–61, 1982
Paiva ES, Linnoila M, Routledge P, et al: Actions and interactions of diazepam and alcohol on psychomotor skills in young and middle-aged subjects. Acta Pharmacol Toxicol 50: 363–369, 1982
Sellers EM, Kalant H: Alcohol intoxication and withdrawal. N Engl J Med 294: 757–762, 1976
Olsen RW: GABA-benzodiazepine-barbiturate receptor-ionophore complex. Mol Cell Biochem 39: 261–279, 1981
Davis WC, Ticku M: Ethanol enhances 3H-diazepam binding at the benzodiazepine-gammaaminobutyric acid receptor-ionophore complex. Mol Pharmacol 20: 287–294, 1981
Karobeth M, Rogers J, Bloom F: Benzodiazepine receptors remain unchanged after chronic ethanol administration. Neuropharmacology 19: 125–128, 1980
Ticku M, Burch TP, Davis WC: The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex. Pharmacol Biochem Behav 18(Suppl 1):15–18, 1983
Kochman RL, Hirsch JD, Clay GA: Changes in H-diazepam receptor binding after subacute ethanol administration. Res Commun Subst Abuse 2: 135–144, 1981
Freund G: Benzodiazepine receptor loss in brains of mice after chronic ethanol consumption. Life Sci 27: 987–992, 1980
Michaelis EK, Mulvaney MJ, Freed W.1: Effects of acute and chronic ethanol intake on synaptosomal glutamate binding activity. Biochem Pharmacol 27: 1685–1691, 1978
Michaelis EK, Chang HH, Roy S, et al: Ethanol effects on synaptic glutamate receptor function and on membrane lipid organization. Pharmacol Biochem Behav 18 (Suppl 1): 1–6, 1983
Olson G, Olson RD, Kastin Ai, et al: Endogenous opiates: 1981. Peptides 3: 1039–1072, 1982
Guerin JM, Friedberg G: Naloxone and ethanol intoxication. Ann Intern Med 97: 932, 1982
Jefferys DB, Flanagan RF, Volans GN: Reversal of ethanol-induced coma by naloxone. Lancet 1: 308–309, 1980
Lyon LJ, Antony J: Reversal of alcohol coma by naloxone. Ann Intern Med 96: 464–465, 1982
Khanna JM, Mayer JM, Kalant H, et al: Effect of naloxone on ethanol-and pentobarbital-induced narcosis. Can J Physiol Pharmacol 60: 1315–1318, 1982
Jeffcoate WJ, Herbert M, Cullen MH, et al: Prevention of the effects of alcohol intoxication by naloxone. Lancet 2: 1157–1159, 1979
Sorenson SC, Mattison K: Naloxone as an antagonist in severe alcohol intoxication. Lancet 2: 688–689, 1978
Triana E, Frances RI, Stokes PE: The relationship between endorphins and alcohol-induced subcortical activity. Am J Psychiatry 137: 491–493, 1980
Lignian H, Fontaine J, Askenasi R: Naloxone and alcohol intoxication in the dog. Hum Toxicol 2: 221–225, 1983
Hemmingsen R, Sorensen SC: Absence of an effect of naloxone on ethanol intoxication and withdrawal reaction. Acta Pharmacol Toxico 46: 62–65, 1980
Manila MJ, Nuomo E, Seppalla T: Naloxone is not an effective antagonist of ethanol. Lancet 1: 775–776, 1981
Sawynok J, Pinsky C, LaBella FS: Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25: 1621–1632, 1979
Boada J, Feria M, Sanz E: Inhibitory effect of naloxone on ethanol-induced antinociception. Pharmacol Res Commun 13: 673–678, 1981
Berkowitz BA, Finck AD, Ngai SH: Nitrous oxide analgesia: Reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 203: 539–547, 1976
Badawy AA-B, Evans M: The mechanism of the antagonism by naltrexone of acute alcohol intoxication. Br J Pharmacol 74: 514–516, 1981
Kiianmaa K, Hoffman PL, Tabakoff B: Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57B1/6 and DBA/2 mice. Psychopharmacology 79: 291–294, 1983
Cicero TJ, Newman KS, Gerrity M, et al: Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat. Life Sci 31: 1587–1596, 1982
Seizinger BR, Bovermann K, Maysinger D, et al: Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of brain and pituitary. Pharmacol Biochem Behav 18 (Suppl 1): 361–369, 1983
Schulz R, Wuster M, Duka T, et al: Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology 68: 221–227, 1980
Ryder S, Straus E, Lieber CS, et al: Cholecystokinin and enkephalin levels following ethanol administration in rats. Peptides 2: 223–226, 1981
Gianoulakis C, Woo N, Drovin JN, et al: Biosynthesis of beta-endorphin by the neurointermediate lobe from rats treated with morphine or alcohol. Life Sci 29: 1973–1982, 1981
Genazzani AR, Nappi G, Facchinetti F, et al: Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab 55: 583–586, 1982
Borg S, Kvande H, Rydberg U, et al: Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal. Psychopharmacology 78: 101–103, 1982
Pfeiffer A, Herz A: Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique. Mol Pharmacol 21: 266–271, 1981
Hiller JM, Angel LM, Simon EJ: Multiple opiate receptors: Alcohol selectively inhibits binding to delta receptors. Science 214: 468–469, 1981
Gianoulakis C: Long-term ethanol alters the binding of ‘H-opiates to brain membranes. Life Sci 33: 725–733, 1983
Tabakoff B, Hoffman PL: Alcohol interactions with brain opiate receptors. Life Sci 32: 192–204, 1983
Jorgensen H, Hole K: Does ethanol stimulate brain opiate receptors? Studies on receptor binding and naloxone inhibition of ethanol-induced effects. Eur J Pharmacol 75: 223–229, 1981
Hoffman PL, Chung CT, Tabakoff B: Effects of ethanol, temperature, and endogenous regulatory factors on the characteristics of striatal opiate receptors. J Neurochem 43: 1003–1010, 1984
Hoffman PL, Tabakoff B: Ethanol modulates the physiological regulation of opiate receptor function. Alcoholism: Clin Exp Res 7 (1): 112, 1983
Levine AS, Hess S, Morley JE: Alcohol and the opiate receptor. Alcoholism: Clin Exp Res 7: 83–84, 1983
Pert CB, Snyder SH: Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol Pharmacol 10: 868–879, 1974
Pfeiffer A, Sadee W, Herz A: Differential regulation of the mu, delta and kappa opiate receptor subtypes by guanyl nucleotide and metal ion. Neuroscience 7: 912–917, 1982
Hoffman PL, Urwyler S, Tabakoff B: Alterations in opiate receptor function after chronic ethanol exposure. J Pharmacol Exp Ther 222: 182–189, 1982
Tabakoff B, Urwyler S, Hoffman PL: Ethanol alters kinetic characteristics and function of striatal morphine receptors. J Neurochem 37: 518–521, 1981
Pfeiffer A, Seizinger BR, Herz A: Chronic ethanol imbibition interferes with S, but not with opiate receptors. Neuropharmacology 20: 1229–1232, 1981
Wood PL, Stotland M, Richard JW, et al: Actions of mu, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther 215: 697–703, 1980
Stein L, Belluzzi JD: Brain endorphins: Possible role in reward and memory formation. Fed Proc 38: 2468–2472, 1979
Routtenberg A: Participation of brain stimulation reward substrates in memory: Anatomical and biochemical evidence. Fed Proc 38: 2446–2453, 1979
Littenger D, Frye GD, Nemeroff CB, et al: The effects of neurotensin, beta-endorphin and bombesin on ethanol-induced behaviors jn mice. Psychopharmacology 79: 357–363, 1983
Hoffman PL: Structural requirements for neurohypophyseal peptide maintenance of ethanol tolerance. Pharmacol Biochem Behav 17: 685–690, 1982
Hoffman PL, Ritzmann RF, Walter R, et al: Arginine vasopressin maintains ethanol tolerance. Nature 276: 614–616, 1978
Hoffman PL, Ritzmann RF, Tabakoff B: Neurohypophyseal peptide influences on ethanol tolerance and acute effects of ethanol. Pharmacol Biochem Behav 13 (Suppl 1): 279–284, 1980
Rigter H, Rijk H, Crabbe JC: Tolerance to ethanol and severity of withdrawal in mice are enhanced by a vasopressin fragment. Eur J Pharmacol 64: 53–68, 1980
Le AD, Kalant H, Khanna JM: Interaction between des-glycinamide-[Arg]vasopressin and serotonin on ethanol tolerance. Eur J Pharmacol 80: 337–345, 1982
Bartholini G, Stadler H: Cholinergic and GABA ergic influence on the dopamine release in extrapyramidal centers, in Almgren O, Carlsson A, Engel J (eds): Chemical Tools in Catecholamine Research, Vol 2. Amsterdam, North-Holland, 1976, pp 235–241
Moore EK, Wuerthele SM: Regulation of nigro-striatal and tuberoinfundibular-hypophyseal dopaminergic neurons. Prog Neurobiol 13: 325–359, 1979
Stadler H, Lloyd KG, Gadea-Ciria M, et al: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res 55: 476–480, 1973.
Kebabian 1W: Biochemical regulation and physiological significance of cyclic nucleotides in the nervous system. Adv Cyclic Nucleotide Res 8: 421–508, 1977
Pittman QJ, Rogers J, Bloom FE: Arginine vasopressin deficient Brattleboro rats fail to develop tolerance to the hypothermic effects of ethanol. Regul Pept 4: 33–41, 1982
Shen A, Jacobyansky A, Smith T, et al: Cyclic adenosine 3’,5’-monophosphate, adenylate cyclase and physical dependence on ethanol: Studies with tranylcypromine. Drug Alcohol Depend 2: 431–440, 1977
Volicer L, Hurter BP: Effects of acute and chronic ethanol administration and withdrawal on adenosine 3’,5’-monophosphate and guanosine 3’,5’-monophosphate levels in the rat brain. J Pharmacol Exp Ther 200: 298–305, 1977
Orenberg EK, Renson J, Barchas JD: The effects of alcohol on cyclic AMP in mouse brain. Neurochem Res 1:659–667, 1976
Redos JD, Hunt WA, Catravas GN: Lack of alteration in regional brain adenosine-3’,5’-cyclic monophosphate levels after acute and chronic treatment with ethanol. Life Sci 18: 989–992, 1976
Ferko AP, Bobyock E, Chernick WS: Regional rat brain content of adenosine 3’,5’-cyclic monophosphate and guanosine 3’,5’-cyclic monophosphate after acute and subacute treatment with ethanol. Toxicol Appl Pharmacol 4: 447–455, 1982
Kuriyama K, Israel MA: Effect of ethanol administration on cyclic 3’,5’-adenosine mono-phosphate metabolism in brain. Biochem Pharmacol 22: 2919–2922, 1973
Zimmer R, Cramer H, Athen D, et al: Changes in cerebrospinal fluid cyclic nucleotides in alcohol-dependent patients suffering from delerium tremens. Biol Psychiatry 17: 837–843, 1982
Dodson RA, Johnson WE: Effects of ethanol, arecoline, atropine and nicotine, alone and in various combinations, on rat cerebellar cyclic guanosine 3’,5’-monophosphate. Neuropharmacology 18: 871–876, 1979
Hunt WA, Redos JD, Dalton TK, et al: Alterations in brain cyclic guanosine 3’,5’-monophosphate levels after acute and chronic treatment with ethanol. J Pharmacol Exp Ther 201: 103–109, 1977
Church AC, Feller D: The influence of mouse genotype on the changes in brain cyclic nucleotide levels induced by acute alcohol administration. Pharmacol Biochem Behav 10: 335–338, 1979
Kuriyama K: Ethanol-induced changes in activities of adenylate cyclase, guanylate cyclase and cyclic adenosine 3’,5’-monophosphate dependent protein kinase in the brain and liver. Drug Alcohol Depend 2: 335–348, 1977
Israel MA, Kimura H, Kuriyama K: Changes in activity and hormonal sensitivity of brain adenyl cyclase following chronic ethanol administration. Experientia 28: 1322–1323, 1972
Volicer L, Mirin R, Gold BI: Effect of ethanol on the cyclic AMP system in rat brain. J Stud Alcohol 38: 11–24, 1977
Hoffman PL, Tabakoff B: Effects of ethanol on Arrhenius parameters and activity of mouse striatal adenylate cyclase. Biochem Pharmacol 31.3101–3106, 1982
von Hungen K, Baxter CF: Sensitivity of rat brain adenylate cyclase to activation by calcium and ethanol after chronic exposure to ethanol. Biochem Biophys Res Commun 106: 1078–1082, 1982
Spiegel AM, Downs RW Jr: Guanine nucleotides: Key regulators of hormone receptor-adenylate cyclase interaction. Endocr Rev 2: 275–305, 1981
Stadel JM, deLean A, Lefkowitz RI: Molecular mechanisms of coupling in hormone receptoradenylate cyclase systems. Adv Enzymol 53: 1–43, 1982
Cooper DMF: Biomodal regulation of adenylate cyclase. FEBS Lett 138: 157–163, 1982
Hoffman PL, Luthin GR, Theodoropoulos D, et al: Ethanol effects on striatal dopamine receptor-coupled adenylate cyclase and on striatal opiate receptors. Pharmacol Biochem Behav 18 (Suppl 1): 355–359, 1983
Luthin GR, Tabakoff B: Activation of adenylate cyclase by alcohols requires the nucleotide-binding protein. J Pharmacol Exp Ther 228: 579–587, 1984
Rabin RA, Molinoff PB: Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther 227: 551–556, 1983
Kamikubo K, Nozaki M, Fujimura H: Inhibition of adenylate cyclase by GTP and its modulation by opiate receptor in rat caudate nucleus. Jpn J Pharmacol 31: 175–184, 1981
Law PY, Wu J, Koehler JE, et al: Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase. J Neurochem 36: 1834–1846, 1981
Cooper DMF, Londos C, Gill DL, et al: Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes. J Neurochem 38: 1164–1167, 1982
Blume AJ, Lichtshtein D, Boone G: Coupling of opiate receptors to adenylate cyclase: Requirement for Na* and GTP. Proc Nat! Acad Sci USA 76: 5626–5630, 1979
Michel T, Lefkowitz RI: Hormonal inhibition of adenylate cyclase. J Bio! Chem 257: 13557–13563, 1982
Koski G, Streaty RA, Klee WA: Modulation of sodium-sensitive GTPase by partial opiate agonists. J Bio! Chem 257: 14035–14040, 1982
Childers SR, Snyder SH: Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J Neurochem 34: 583–593, 1980
Rubin E, Rottenberg H: Ethanol and biological membranes: Injury and adaptation. Pharmacol Biochem Behav 18 (Suppl l): 7–13, 1983
Goldstein DB, Chin JA, Lyon RC: Ethanol disordering of spin-labeled mouse brain membranes: Correlation with genetically determined ethanol sensitivity of mice. Proc Natl Acad Sci USA 79: 4231–4233, 1982
Harris RA, Schroeder F: Ethanol and the physical properties of brain membranes: Fluorescence studies. Mol Pharmacol 20: 128–137, 1981
Chin JH, Goldstein DB: Drug tolerance in biomembranes: A spin-label study of the effects of ethanol. Science 196: 684–685, 1976
Goldstein DB, Chin JH, Lyon RC: Ethanol disordering of spin-labelled mouse brain membranes: Correlation with genetically-determined ethanol sensitivity of mice. Proc Natl Acad Sci USA 79: 4231–4233, 1982
Farias RN, Bloj B, Morero RD, et al: Regulation of allosteric membrane-bound enzymes through changes in membrane lipid composition. Biochim Biophys Acta 415: 231–251, 1975
Harris RA, Schroeder F: Effects of barbiturates and ethanol on the physical properties of brain membranes. J Pharmacol Exp Ther 223: 424–431, 1982
Chin JH, Goldstein DB: Membrane disordering action of ethanol. Variation with membrane cholesterol content and depth of the spin-label probe. Mol Pharmacol 19: 425–431, 1981
Johnson DA, Lee NM, Cooke R, et al: Ethanol-induced fluidization of brain lipid biolayers: Required presence of cholesterol in membranes for the expression of tolerance. Mol Pharmacol 15: 739–746, 1979
Chin JH, Parsons LM, Goldstein DB: Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice. Biochim Biophys Acta 513: 358–363, 1978
Smith TL, Gerhart MJ: Alterations in brain lipid composition of mice made physically dependent on ethanol. Life Sci 31: 1419–1425, 1982
Parsons LM, Gallaher EJ, Goldstein DB: Rapidly developing functional tolerance to ethanol is accompanied by increased erythrocyte cholesterol in mice. J Pharmacol Exp Ther 223: 472–476, 1982
Lyon RC, Goldstein DB: Changes in synaptic membrane order associated with chronic ethanol treatment in mice. Mol Pharmacol 23: 86–91, 1983
Vrbaski SR, Grujic-Injac B, Ristic M: Effect of dietary protein level on brain phospholipids during chronic ethanol consumption. Res Commun Subst Abuse 1: 349–352, 1980
Ailing C, Liljequist S, Engel J: The effect of chronic ethanol administration on lipids and fatty acids in subcellular fractions of rat brain. Med Biol 60: 149–154, 1982
Ingram LO, Ley KD, Hoffman EM: Drug-induced changes in lipid composition of E. coli and of mammalian cells in culture: Ethanol, pentobarbital and chlorpromazine. Life Sci 22: 489–494, 1978
Sun GY, Sun AY: Effect of chronic ethanol on phospholipid acyl groups of synaptic plasma membrane fraction isolated from guinea pig brain. Res Commun Chem Pathol Pharmacol 24: 405–408, 1979
Littleton JM, John G: Synaptosomal membrane lipids of mice during continuous exposure to ethanol. J Pharm Pharmacol 29: 579–580, 1977
Littleton JM, John GR, Grieve SJ: Alterations in phospholipid composition in ethanol tolerance and dependence. Alcoholism: Clin Exp Res 3: 50–56, 1979
Beaugé F, Stibler H, Kalant H: Brain synaptosomal (Na and K+)ATPase activity as an index of tolerance to ethanol. Pharmacol Biochem Behav 18 (Suppl 1): 519–524, 1983
Guerri C, Grisolia S: Chronic ethanol treatment affects synaptosomal membrane-bound enzymes. Pharmacol Biochem Behav 18 (Suppl 1): 45–50, 1983
Lenaz G, Curatola G, Masotti L: Perturbation of membrane fluidity. J Bioenerg Biomembr 7: 223–299, 1975
Sedman GL, Austin L, Langford CJ: Protein turnover in brain during the development of alcohol dependence. Neurosci Lett 28: 93–99, 1982
Goertz B: Effect of ethanol on rat brain protein synthesis. Exp Brain Res 48: 438–442, 1982
Noble EP, Tewari S: Protein and rinonucleic acid metabolism in brains of mice following chronic alcohol consumption. Ann NY Acad Sci 215: 333–345, 1973
Tewari S, Fleming EW, Noble EP: Alterations in brain RNA metabolism following chronic ethanol ingestion. J Neurochem 24: 561–569, 1975
Jarlstedt J: Experimental alcoholism in rats: Protein synthesis in subcellular fractions from cerebellum, cerebral cortex and liver after long-term treatment. J Neurochem 19: 603–608, 1972
Renis M, Giovine A, Bertolina A: Protein synthesis in the mitochondrial and microsomal fraction from rat brain after acute or chronic ethanol administration. Life Sci 16: 1447–1457, 1975
Frankel D, Khanna JM, LeBlanc AE, et al: Effect of p-chlorophenylalanine on the acquisition of tolerance to ethanol and pentobarbital. Psychopharmacologia 44: 247–252, 1975
Frankel D, Khanna JM, Kalant H, et al: Effect of p-chlorophenylalanine on the acquisition of tolerance to the hypothermic effects of ethanol. Psychopharmacology 57: 239–242, 1978
Le AD, Khanna JM, Kalant H, et al: Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol. Psychopharmacology 67: 143–146, 1980
Khanna JM, Kalant H, Le AD, et al: Role of serotonergic and adrenergic systems in alcohol tolerance. Prog Neuropsychopharmacol Biol Psychiatry 5: 459–465, 1981
Wood JM: Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat. Psychopharmacology 67: 67–72, 1980
Ritzmann RF, Tabakoff B: Dissociation of alcohol tolerance and dependence. Nature 263: 418–420, 1976
Wood JM, Laverty R: Effect of depletion of brain catecholamine on ethanol tolerance and dependence. Eur J Pharmacol 58: 285–293, 1979
Le AD, Poulos CS, Cappell H: Conditioned tolerance to the hypothermic effect of ethyl alcohol. Science 206: 1109–1110, 1979
Crowell CR, Hinson RE, Siegel S: The role of conditioned drug responses in tolerance to the hypothermic effects of ethanol. Psychopharmacology 73: 51–54, 1981
Hinson RE, Siegel S: The contribution of Pavlovian conditioning to ethanol tolerance and dependence, in Rigter H, Crabbe JC (eds): Alcohol Tolerance and Dependence. Amsterdam, Elsevier/North-Holland Biomedical Press, 1980 p 181
Mansfield JB, Cunningham CL: Conditioning and extinction of tolerance to the hypothermic effect of ethanol in rats. J Comp Physiol Psychol 94: 962–969, 1980
Melchior CL, Tabakoff B: Modification of environmentally-cued tolerance to ethanol in mice. J Pharmacol Exp Ther 219: 175–180, 1981
Hoffman PL, Melchior CL, Tabakoff B: Vasopressin maintenance of ethanol tolerance requires intact brain noradrenergic systems. Life Sci 32: 1065–1071, 1983
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hoffman, P.L., Tabakoff, B. (1985). Ethanol’s Action on Brain Biochemistry. In: Tarter, R.E., van Thiel, D.H. (eds) Alcohol and the Brain. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9134-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9134-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9136-5
Online ISBN: 978-1-4757-9134-1
eBook Packages: Springer Book Archive